27/10/2026 - General information
The World's Top 2% Scientists ranking, which includes the world's most influential researchers, features 44 professionals affiliated with Hospital del Mar and the Hospital del Mar Research Institute (HMRIB) in its latest edition. The list, compiled by Stanford University in the United States, takes into account the most highly cited scientists across a range of disciplines. Researchers are classified into 22 scientific fields and 174 subfields, and the ranking includes 100,000 individuals, representing the top 2% of active scientists worldwide. The ranking comprises two lists. One takes into account researchers' entire careers, while the other considers only citation data from scientific publications in recent years.
26/10/2026 - General information
The study, published in JAMA Neurology, shows that early communication of blood biomarker results improves diagnostic certainty for Alzheimer's disease and enables optimisation of the clinical management of patients with cognitive symptoms, without having a negative emotional impact. The research analysed the progress of 220 patients in the PLASMAR study, divided according to whether they received their biomarker results after three or nine months. Receiving them earlier made it possible to bring forward clinical decision-making and provide more efficient patient follow-up. The results show that communicating the results early, after three months, also reduced follow-up tests and unnecessary reassessments, particularly in patients with a low probability of Alzheimer's disease, without increasing levels of anxiety, depression or stress.
21/10/2026 - General information
The Societat Catalana de Farmàcia Clínica has awarded the Joaquim Bonal Grant to the project 'Estratègies innovadores per al monitoratge de precisió del linezolid mitjançant biomarcadors no invasius i farmacogenètica', led by Sònia Luque and Pau Riera, from the Pharmacy Department at Hospital del Mar and researchers at the Hospital del Mar Research Institute. This prestigious recognition in the field of clinical pharmacy will support a project aimed at validating non-invasive alternatives for monitoring the antibiotic linezolid and analysing the usefulness of pharmacogenetics to optimise its use. Linezolid is used to treat severe infections caused by multidrug-resistant Gram-positive bacteria. Its prolonged use may be limited by the onset of adverse effects, including haematological toxicity, the incidence of which increases significantly when treatment lasts more than two weeks and is particularly high in patients who require several weeks or months of therapy.
19/10/26 - General information
From November 23 to 27, Hospital del Mar hosts Innovation Week, a space to share ideas, connect knowledge, and foster new ways of transforming healthcare. Under the concept of iNOVA, the week aims to highlight the innovation generated every day across the Hospital and showcase the people and projects that help drive the organization forward. Research, healthcare, technology, and innovation come together in a programme designed to connect perspectives and create new opportunities.
14/10/2026 - General information
The International Society of Paediatric Oncology (SIOP) has awarded the Odile Schweisguth Award to research on Ewing sarcoma carried out by Dr Irene Cuervas, a researcher at the Hospital del Mar Research Institute and the Sant Joan de Déu Research Institute (IRSJD). The study was co-led by Dr Inmaculada Hernández-Muñoz, a researcher with the Dermatological Inflammatory and Neoplastic Diseases Research Group at HMRIB, and Dr Jaume Mora, head of the Sarcoma and Neuroblastoma Research Group at IRSJD, and was conducted in collaboration with the Centre for Genomic Regulation (CRG).
13/10/2026 - General information
Research in the field of frailty and kidney transplantation, led by the Nephrology and Physical Medicine and Rehabilitation Departments at Hospital del Mar and researchers from the Hospital del Mar Research Institute, has received the Nephrology Research Award at the Íñigo Álvarez de Toledo Awards for Nephrology Research, presented by the Spanish Kidney Foundation. The award jury, made up of 22 experts in nephrology, research and business, granted two awards: one for nephrology and another for nephrology nursing, which, in this edition, was shared by two projects.
01/10/2026 - General information
Dr Sara Mederos, coordinator of the Neural Computation Laboratory at the Hospital del Mar Research Institute (HMRIB), is one of the researchers selected in the twelfth edition of the BBVA Foundation Leonardo Grants. Her project, 'Reorganization of Hippocampal-Prefrontal Learning Across Pregnancy', is one of 59 selected from nearly 1,900 proposals submitted. The project led by Dr Mederos aims to deepen our understanding of how neural circuits reorganise during pregnancy and the postpartum period. The research will focus on circuits involving the hippocampus and the prefrontal cortex, two brain regions that work together to build and update memories, guide decision-making and adapt behaviour to changes in the environment. The proposal was selected in the field of Biology and Medicine, one of the eleven areas covered by the Leonardo Grants.
Més informació "BBVA Foundation Leonardo Grant awarded to Dr Sara Mederos"
29/09/2026 - General information
The next Saturday 3 October marks a new edition of the PRBB Open Day. Once again, the building will open its doors to the public to discover first-hand the research carried out there, visit laboratories and scientific services, and meet the people who work there. Throughout the morning, from 10.00 am to 2.00 pm, professionals from the different PRBB research centres will share their day-to-day work and bring science closer to the public through a range of activities and guided tours. This year, OpenPRBB is placing a special focus on guided tours, offering an opportunity to access spaces that are not usually open to the public, discover one of Barcelona's major scientific infrastructures, and see how research is carried out from the inside.
Més informació "OpenPRBB 2026: on Saturday 3 October, experience science up close"
22/09/2026 - General information
Dr Anna Bigas, head of the Stem Cells and Cancer Group at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, has joined the Board of Trustees of the Scientific Foundation of the Spanish Association Against Cancer as a scientific trustee. Her appointment took effect at the foundation's Board meeting held in Madrid on 17 September. Dr Bigas joins a select group of scientists who help guide the foundation's decisions regarding the selection of projects for funding and the definition of its main research priorities. "It is an honour to contribute to ensuring that cancer research is the best it can be," she explains. "Joining this Board of Trustees gives me the opportunity to draw on my experience as a researcher to help support high-quality cancer science and ensure that it reaches patients sooner," she adds.
21/09/2026 - General information
Alzheimer's research has reached a pivotal moment. Advances made in recent years point towards a new era in the diagnosis and treatment of the disease, one of the leading causes of dementia worldwide, affecting more than 800,000 people in Spain alone. To examine where we are now and where the field is heading, The Lancet has published an in-depth Seminar article aimed at medical students and healthcare professionals who are not specialists in this area. Among the seven international experts selected to prepare the article is Dr Marc Suárez-Calvet, from the Barcelona Brain Health Center (BBHC) at Hospital del Mar, the Hospital del Mar Research Institute and the Barcelonaβeta Brain Research Center of the Pasqual Maragall Foundation. Below, he outlines the main conclusions.
Més informació "A new era in the history of Alzheimer's disease"
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
